Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T12:32:34.542Z Has data issue: false hasContentIssue false

CO2-laser treatment of laryngeal amyloidosis

Published online by Cambridge University Press:  08 March 2006

Gaetano Motta
Affiliation:
Department of Otorhinolaryngology, II University of Naples, Naples, Italy
Francesco Antonio Salzano
Affiliation:
Department of Otorhinolaryngology, University of Palermo, Palermo, Italy
Sergio Motta
Affiliation:
Department of Otorhinolaryngology, Areneo ’Federico II’, I University of Naples, Naples, Italy
Stefania Staibano
Affiliation:
Department of Pathology, Areneo ’Federico II’, I University of Naples, Naples, Italy

Abstract

Four consecutive female patients (age: 14–47 years) with laryngeal amyloidosis, treated with endoscopic CO2-laser surgery, entered the study. All patients underwent periodic microlaryngoscopies following surgery to confirm the adequacy of the surgical resection. Recurrences or suspected lesions were resected and fibrin deposits were removed to prevent the formation of synechiae or healing adhesions. After two negative microlaryngoscopies, performed two months apart, the patients were followed-up approximately every six months over a period from six months to 18 years, with no evidence of recurrences. The endoscopic CO2-laser technique is highly effective in the treatment of localized laryngeal amyloidosis.

Type
Research Article
Copyright
© Royal Society of Medicine Press Limited 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)